Findings in this study confirmed the herd immunity effect of immunizing young children, since invasive meningococcal disease was not only reduced among vaccinees, but in all age groups.
ECDC publishes today a report surveying the prevalence of Tick Borne Encephalitis (TBE) in Europe. The report has epidemiological data from 2000 to 2010 for 20 out of 30 EU/EFTA countries. The data shows that a number of key risk areas can be found in Europe in terms of geographic spread, seasonal peaks and at-risk age groups. Most countries in Europe have surveillance systems although some vary which greatly impedes comparability and analysis of TBE.
On 5 September 2012 the European Commission decision amending Decision 2000/96/EC as regards tick-borne encephalitis was published. As a result tick-borne encephalitis is added to the list of diseases to be covered by epidemiological surveillance within the Community.
Carbapenem-resistant Enterobacteriaceae (CRE) or carbapenemase-producing Enterobacteriaceae (CPE) are highly resistant to antibiotics, leaving only a few options for treatment of infected patients, and thus represent a serious threat to public health.
ECDC, through the VBORNET network, publishes regularly on its website maps on exotic mosquitoes and on phlebetomines - to provide the ECDC stakeholders and the general public with the most updated information on vector distribution. The maps are updated and improved quarterly.
WHO “SAVE LIVES: Clean Your Hands” is an annual campaign that makes part of major global effort to support healthcare workers to improve hand hygiene practices in healthcare settings, and thus support the prevention of often life-threatening healthcare-associated infections.
4CMenB has the potential to reduce serogroup B meningococcal disease substantially. Despite its potential, the vaccine may have some limitations, and it remains to be seen if booster doses will be required to sustain protection.
Slovenia is one of the countries with the highest reported incidence rates of tick-borne encephalitis (TBE). Vaccination uptake is low, estimated to be 12.4%. TBE surveillance data for the last 20 years were analysed.